Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today ...

On Monday, private equity investor TA Associates announced its arrival at Melbourne’s Viridian Financial Group with much ...

Police were called to the Viridian Beach area in the 1200 block of Viridian Park Lane before 6:45 p.m. May 30 to respond to reports of "a large gathering of unsupervised teens" who were "blocking ...

Viridian has agreed to a strategic investment for an undisclosed amount from private equity firm TA Associates.

The Beach at Lake Viridian was initially closed on May 30 after Arlington police were called to clear 300 teenagers from the ...

Viridian manages around $16bn in funds across Viridian Advisory, Infinity Capital Solutions, Smartmove Lending.

It spells a payday for Melbourne’s Viridian Advisory, which shot to prominence six years ago when it acquired Westpac’s ...

Viridian Therapeutics (NASDAQ:VRDN) reported positive topline results from the THRIVE-2 phase 3 trial of veligrotug (VRDN-001) in chronic thyroid eye disease (‘TED’) patients.

Viridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage study, sending its shares ...

Viridian Therapeutics (VRDN) announced topline data from the THRIVE-2 phase 3 clinical trial of veligrotug, an intravenously delivered anti-insulin-like growth factor-1 receptor antibody, in ...

TA Associates announced it will make an undisclosed investment in Viridian Financial Group to help the latter accelerate its next phase of growth.

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines ...